SCHEMBL27660968

SCHEMBL27660968

CCCCc1ccnc(C)c1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 4/20 0.41
TLR8 Q9NR97 6/20 0.40
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRB1 P18505 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
GABRB2 P47870 1/20 0.37
GABRA4 P48169 1/20 0.37
GABRE P78334 1/20 0.37
GABRA6 Q16445 1/20 0.37
GABRG1 Q8N1C3 1/20 0.37
GABRG3 Q99928 1/20 0.37
GABRQ Q9UN88 1/20 0.37
SKP2 Q13309 1/20 0.37
NOS3 P29474 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27900729 0.83 TLR8 (0.47) NOS2TLR8GABRPGABRDGABRA1
SCHEMBL27570675 0.81 TYR (0.37) NOS2TLR8GABRPGABRDGABRA1
SCHEMBL26489048 0.80 NOS2 (0.44) NOS2NOS3
SCHEMBL15528179 0.78 NOS2 (0.49) NOS2TLR8GABRPGABRDGABRA1
SCHEMBL25886999 0.77 TLR8 (0.37) NOS2TLR8GABRPGABRDGABRA1
Hexane SCHEMBL28173825 0.77 NOS2 (0.52) NOS2TLR8SKP2NOS3SMN1; SMN2
SCHEMBL21834060 0.76 ALDH1A1 (0.37) NOS2TLR8CA2
SCHEMBL11379212 0.76 TYR (0.41) NOS2TLR8TYRHTR2AHTR2C
SCHEMBL840920 0.75 TYR (0.48) NOS2TLR8GABRPGABRDGABRA1
SCHEMBL8916740 0.75 TLR8 (0.40) NOS2TLR8HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1930144-A 3-'4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases BOEHRINGER INGELHEIM PHARMA (US) 2007-03-14 CN disclosed